Parra, G. A., H. H. Lindarte, and A. F. Rubio. “Over Optimum Response to PCSK-9 Inhibitors: ¿is It Mandatory to Supply Them Every 2 weeks?, about a Case”. Revista Colombiana de Endocrinología, Diabetes & Metabolismo 7, no. 1 (April 24, 2020): 43–44. Accessed July 16, 2024. https://revistaendocrino.org/index.php/rcedm/article/view/568.